Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 12108073 | HLA-DR (HLA-DR) | septicemia | NA | NA | NA | positive+negation | |
| average percentage of cd3+ (69.2 +/- 5.9%), cd4+ (48.9 +/- 10.7%) and hla-dr+ (1.8 +/- 0.9%) lymphocytes and average cd4+/cd8+ ratio (2.97 +/- 1.33) in neonates with septicemia did not significantly differ from average values of these parameters in healthy neonates that were: cd3+ (69.1 +/- 9.0%), cd4+ (47.4 +/- 10.6%), hla-dr+ (1.5 +/- 0.5%) and cd4+/cd8+ (2.29 +/- 1.29). | |||||||
| 12875677 | HLA IDENTICAL (HLA-IDENTICAL) | septicemia | NA | cyclophosphamide | NA | unclassified | |
| a patient with saa and pseudomonas aeruginosa septicemia was treated with pbsct from an hla-identical sibling with cyclophosphamide (cy) and total body irradiation (tbi) for conditioning. | |||||||
| 12130967 | HLA-DR (HLA-DR) | ventilator-associated pneumonia | NA | NA | NA | negative | |
| the administration of interferon-gamma resulted in the recovery of levels of human leukocyte antigen-dr expression in alveolar macrophages, influenced the inflammatory reaction, and decreased the incidence ventilator-associated pneumonia, without affecting the patients' outcome. | |||||||
| 27324766 | HLA (HLA) | ventilator-associated pneumonia | NA | NA | NA | unclassified | |
| a monoclonal antibody targeting hla, medi4893, is in clinical development for the prevention of s. aureus ventilator-associated pneumonia (vap). | |||||||
| 12139242 | HLA-DQB1 (HLA-DQB1) | pyrose | NA | NA | NA | unclassified | |
| pyrosequence-based typing of alleles of the hla-dqb1 gene. | |||||||
| 12139242 | NA (NA) | pyrose | NA | NA | NA | unclassified | |
| dna typing of alleles of the highly polymorphic hla-dqbi gene was performed by pyrosequencing using purified dna from the 11th international histocompatibility workshop human cell lines and samples from the children's hospital of pittsburgh registry of diabetics and their first-degree relatives. | |||||||
| 12139242 | HLA-DQB1 (HLA-DQB1) | pyrose | NA | NA | NA | unclassified | |
| pyrosequencing was optimized for genotyping exon 2 of the hla-dqb1 gene, but the procedure should be applicable to other hla loci. | |||||||
| 12139242 | HLA-DQB1 (HLA-DQB1) | pyrose | NA | NA | NA | only_studied | |
| the 61 polymorphic residues of dqb1 exon 2 were identified within four pyrosequencing reactions, obtained by a 70-nucleotide read length in each reaction, in about an hour's time. | |||||||
| 12139242 | HLA (HLA) | pyrose | NA | NA | NA | unclassified | |
| pyrosequence-based typing is compatible with genotyping of allelic combinations expected from heterozygous individuals, resulting in nucleotide resolution of the highly polymorphic hla system. | |||||||
| 14641938 | HLA (HLA) | pyrose | NA | NA | NA | unclassified | |
| pyrosequencing trade mark : a one-step method for high resolution hla typing. | |||||||
Copyright 2024